Detection of in vivo biomarkers of phospholipidosis using NMR‐based metabonomic approaches

The application of high‐field 1H NMR spectroscopy to the analysis of biological fluids has proved to be a valuable approach to toxicological screening. Coupled with data reduction and chemometric analyses, this technology has a high capacity for elucidating relevant metabolic information pertaining to the nature and mechanism of toxic processes in an organism. This approach is encapsulated in the concept of metabonomics, which is defined as ‘the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification’, and can be regarded as complementary to studies of the genome (genomics) and the proteins in an organism (proteomics). Here the metabonomics approach to drug toxicity evaluation is exemplified using 1H NMR spectroscopy to investigate the biochemical perturbations in urine after dosing Fischer rats with the cationic, amphiphilic drugs chloroquine, amiodarone and DMP 777, a neutrophil elastase inhibitor. These drugs are known to induce phospholipidosis, characterized by lysosomal lamellar body and drug accumulation. Using a metabonomic approach, combinations of specific urinary biomarkers were identified for each compound, together with a putative general marker of phospholipidosis, phenylacetylglycine. Furthermore, in the case of chloroquine, clear evidence of hepatotoxicity was determined. Copyright © 2001 John Wiley & Sons, Ltd.

[1]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[2]  B. Kowalski,et al.  Pattern recognition. Powerful approach to interpreting chemical data , 1972 .

[3]  V. Ferrans,et al.  Chloroquine‐Induced Cardiomyopathy , 1993, Circulation.

[4]  Svante Wold,et al.  Pattern recognition by means of disjoint principal components models , 1976, Pattern Recognit..

[5]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[6]  J C Lindon,et al.  Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data , 1990, NMR in biomedicine.

[7]  C. Mason.  Ocular accumulation and toxicity of certain systemically administered drugs. , 1977, Journal of toxicology and environmental health.

[8]  S. Ruangkanchanasetr,et al.  Ocular toxicity of chloroquine among Thai patients , 1999, International journal of dermatology.

[9]  P J Sadler,et al.  High resolution 1H n.m.r. studies of vertebrate blood and plasma. , 1983, The Biochemical journal.

[10]  E Holmes,et al.  Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. , 2001, Chemical research in toxicology.

[11]  S. Connor,et al.  Antidiabetic Efficacy of BRL 49653, a Potent Orally Active Insulin Sensitizing Agent, Assessed in the C57BL/KsJ db/db Diabetic Mouse by Non‐invasive 1H NMR Studies of Urine , 1997, The Journal of pharmacy and pharmacology.

[12]  F. Tremel,et al.  Chloroquine cardiomyopathy with conduction disorders , 1999, Heart.

[13]  P J Sadler,et al.  Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. , 1984, The Biochemical journal.

[14]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[15]  P J Sadler,et al.  Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. , 1984, Clinical chemistry.

[16]  P J Sadler,et al.  Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats. , 1985, Molecular pharmacology.

[17]  J. Nicholson,et al.  A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study , 2000 .

[18]  U. Busch,et al.  A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals , 1997, Microscopy research and technique.

[19]  Paul A. Keifer,et al.  WET Solvent Suppression and Its Applications to LC NMR and High-Resolution NMR Spectroscopy , 1995 .

[20]  E Holmes,et al.  Accelerated toxicity screening using NMR and pattern recognition-based methods. , 2000, Current opinion in drug discovery & development.